Chronic inflammation associated with tumor promotion has also been linked to the activity of the receptor for advanced glycation end-products (RAGE) and RAGE ligands via an in vitro analysis of GBM cell lines and in an in vivo murine model of skin carcinogenesis [144,145]. The gene discussed is AGER; the disease is glioblastoma.